Identificación y tratamiento de los pacientes con miocardiopatía hipertrófica y riesgo de muerte súbitaIdentification and Treatment of Patients with Hypertrophhic Cardiomyopathy at Risk of Sudden Death
Biblografía (59)
- et al.
Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy: a review
Prog Cardiovasc Dis
(1985) - et al.
Prevalence of hypertrophic cardiomyopathy in a population of adult Japanese workers as detected by echocardiographic screening
Am J Cardiol
(1987) - et al.
Prevalence of hypertrophic cardiomyopathy in an outpatient population referred for echocardiographic study
Am J Cardiol
(1994) - et al.
Ocurrence and significance of progressive left ventricular wall thining and relative cavity dilatation in hypertrophic cardiomyopathy
Am J Cardiol
(1987) - et al.
Prognosis in hypertrophic cardiomyopathy. Role of age and clinical, electrocardiographic and haemodynamic features
Am J Cardiol
(1981) - et al.
Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy
J Am Coll Cardiol
(1988) - et al.
Myocardial ischaemia detected by thallium scintrigraphy is frequenly related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy
J Am Coll Cardiol
(1993) - et al.
Sudden death due to troponin T mutations
J Am Coll Cardiol
(1997) - et al.
Clinical features of hypertrophic cardiomyopathy caused by a mutation of a «hot spot» in the alpha-tropomyosin gene
J Am Coll Cardiol
(1997) - et al.
Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study
Am J Cardiol
(1981)
Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death
Am J Cardiol
(1993)
Heart rate variability in patients with hypertrophic cardiomyopathy: association with clinical and echocardiographic features
Am Heart J
(1997)
26.th Bethseda Conference: Recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task force 3: Hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse
J Am Coll Cardiol
(1994)
The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation
J Mol Cell Cardiol
(1997)
Angiotensinogen gene polymorphism in Japanese patients with hypertrophic cardiomyopathy
Am Heart J
(1997)
The management of hypertrophic cardiomyopathy
N Engl J Med
(1997)
Recent advances in the molecular genetics of hypertrophic cardiomyopathy
Circulation
(1995)
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
Nat Genet
(1997)
Hypertrophic cardiomyopathy: interrelations of clinical manifestations, patophysiology, and therapy
N Engl J Med
(1987)
Prevalence of hypertrophic cardiomyopathy in a population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (Young) Adults
Circulation
(1995)
Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatients population
N Engl J Med
(1989)
Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population
J Am Coll Cardiol
(1995)
Hypertrophic cardiomyopathy: an important cause of sudden death
Arch Dis Child
(1984)
Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass
Br Heart J
(1990)
Diagnostic value of electrocardiograhy and echocardiography for familial hypertrophic cardiomyopathy in a genotyped adult population
Circulation
(1997)
Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families
Heart
(1997)
Hypertrophic cardiomyopathy
Sudden death in hypertrophic cardiomyopathy: a profile of 78 patients
Circulation
(1982)
Sudden death in hypertrophic cardiomyopathy: Assessment of patients at high risk
Circulation
(1989)
Cited by (25)
A homozygous MYBPC3 gene mutation associated with a severe phenotype and a high risk of sudden death in a family with hypertrophic cardiomyopathy
2009, Revista Espanola de CardiologiaBeta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy
2006, Revista Espanola de CardiologiaThe implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers
2006, Revista Espanola de CardiologiaHypertrophic myocardiopathy: How to predict its evolution?
2004, Medicina ClinicaHypertrophic myocardiopathy. Management during pregnancy and labour
2004, Clinica e Investigacion en Ginecologia y ObstetriciaDirect detection of malignant mutations in patients with hypertrophic cardiomyopathy
2003, Revista Espanola de Cardiologia
Copyright © 2000 Sociedad Española de Cardiología. Published by Elsevier España, S.L. All rights reserved.